YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2021Metabolic Subtyping of Adrenal Tumors: Prospective Multi-Center Cohort Study in Korea Endocrinology and Metabolism(대한내분비학회지)
2021Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort StudyINFLAMMATORY BOWEL DISEASES
2021Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patientsHEPATOLOGY INTERNATIONAL
2021Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyLANCET
2021Signal transducer and activator of transcription 3 as a potential therapeutic target for Graves' orbitopathyMOLECULAR AND CELLULAR ENDOCRINOLOGY
2021Cardiac Safety Assessment of Lazertinib: Findings From Patients With EGFR Mutation-Positive Advanced NSCLC and Preclinical Studies JTO Clinical and Research Reports
2021Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I StudyJOURNAL OF CLINICAL ONCOLOGY
2021Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational Study JOURNAL OF THORACIC ONCOLOGY
2021Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLCJOURNAL OF THORACIC ONCOLOGY
2021Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer JOURNAL FOR IMMUNOTHERAPY OF CANCER
2021Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors JTO Clinical and Research Reports
2022Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients JOURNAL OF MOLECULAR DIAGNOSTICS
2021COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society Endocrinology and Metabolism(대한내분비학회지)
2021Association of pre-percutaneous coronary flow grade and clinical outcomes in patients with non-ST-segment elevation myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry MEDICINE
2021Efficacy of Statin Treatment According to Baseline Renal Function in Korean Patients with Acute Myocardial Infarction Not Requiring Dialysis Undergoing Newer-Generation Drug-Eluting Stent Implantation JOURNAL OF CLINICAL MEDICINE
2021LncRNA HSPA7 in human atherosclerotic plaques sponges miR-223 and promotes the proinflammatory vascular smooth muscle cell transition EXPERIMENTAL AND MOLECULAR MEDICINE
2021Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer CANCER MEDICINE
2021Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study BMC CARDIOVASCULAR DISORDERS
2021Association of cardiovascular health and incident atrial fibrillation in elderly populationHEART
1 140 141142143144145146147148149150151 691

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links